Biomedical
James P. C. Coverdale,
Sirilata Polepalli,
Marco A. Z. Arruda,
Ana B. Santos da Silva,
Alan J. Stewart,
Claudia A. Blindauer
Peer Reviewed
The article "Recent Advances in Metalloproteomics" provides an overview of the interactions between proteins and metal ions, which are crucial in various biological processes, including physiology, medicine, and toxicology. Despite the essential role of metal ions in sustaining life, the study of metalloproteomes has been challenging due to their complexity and the non-covalent nature of many metal-protein interactions. The review discusses recent methodologies and ongoing challenges in analyzing these interactions, with a particular focus on transition metals from the fourth and fifth periods, many of which are xenobiotic and form stable complexes. The authors also highlight the significance of metallodrug–protein interactions and emphasize the need for specialized separation techniques tailored to the reactivity of specific metals.
Metalloproteomes refer to the complete set of metalloproteins within a cell or organism. These proteins contain metal ions as cofactors, which are essential for various biological functions, including enzyme catalysis, electron transport, and signal transduction. Understanding metalloproteomes is crucial for comprehending the full scope of cellular processes and the impact of metal ions on health and disease.
The study of metalloproteomes is complicated by the complexity of metal-protein interactions and the non-covalent nature of many of these complexes. This complexity makes it difficult to analyze and characterize metalloproteins accurately. Additionally, the presence of labile metal ions and the dynamic nature of metal binding further complicate the study of metalloproteomes.
Transition metals from the fourth and fifth periods, many of which are xenobiotic, tend to form more stable and inert complexes. These stable complexes can have significant biological effects, including interactions with proteins and nucleic acids. Understanding these interactions is essential for elucidating the mechanisms of action of metallodrugs and the potential toxicological effects of these metals.
Metallodrug–protein interactions involve the binding of metal-containing drugs to proteins, which can modulate protein function and influence therapeutic outcomes. These interactions are important because they can lead to the development of new therapeutic agents and provide insights into the mechanisms of action of existing metallodrugs. Understanding these interactions is also crucial for assessing the safety and efficacy of metal-based therapies.
Show by month | Manuscript | Video Summary |
---|---|---|
2025 January | 62 | 62 |
2024 December | 68 | 68 |
2024 November | 81 | 81 |
Total | 211 | 211 |
Show by month | Manuscript | Video Summary |
---|---|---|
2025 January | 62 | 62 |
2024 December | 68 | 68 |
2024 November | 81 | 81 |
Total | 211 | 211 |